Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Lagrange Labs in the transaction. Lagrange Labs announced a $13.2 million Seed Round, led by Founders Fund. The round included...
You must be a Standard 1 Year member to access this content.
Paul Weiss Rifkind Wharton & Garrison is advising IBM on the transaction, and Wilson Sonsini Goodrich & Rosati is advising HashiCorp. IBM (NYSE: IBM) and HashiCorp Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley represented the underwriters. Edgewise Therapeutics, Inc. (“Edgewise”) (NASDAQ: EWTX) announced the pricing of an underwritten...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is advising Rover Group, Inc. on the transaction, and Kirkland & Ellis is advising private equity funds managed by Blackstone. Blackstone...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
You must be a Standard 1 Year member to access this content.
